Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of thromboembolism (tamoxifen, raloxifene), endometrial cancer (tamoxifen) or stroke (tibolone)
- PMID: 20682726
- DOI: 10.1136/ebm1044
Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of thromboembolism (tamoxifen, raloxifene), endometrial cancer (tamoxifen) or stroke (tibolone)
Comment on
-
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.Ann Intern Med. 2009 Nov 17;151(10):703-15, W-226-35. doi: 10.7326/0003-4819-151-10-200911170-00147. Ann Intern Med. 2009. PMID: 19920271
Publication types
LinkOut - more resources
Full Text Sources